Log In
BCIQ
Print this Print this
 

MT-1303

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSphingosine 1-phosphate receptor functional antagonist
Molecular Target Sphingosine 1-phosphate (S1P) receptor
Mechanism of ActionSphingosine 1-phosphate (S1P) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$544.0M

$60.0M

$484.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/09/2015

$544.0M

$60.0M

$484.0M

Get a free BioCentury trial today